NEW YORK, May 30 (GenomeWeb News) - Bruker Daltonics and Protein Discovery will co-market MALDI molecular imaging mass spectrometry products for protein biomarker discovery, the companies said today.
Protein Discovery holds a license from Vanderbilt University to provide imaging mass spectrometry services to customers in the research, pharmaceutical and diagnostics industries. Bruker, meantime, markets the MALDI Molecular Imager for this technique for research use only with Professor Richard Caprioli at Vanderbilt.
Protein Discovery's imaging mass spectrometry service laboratory is currently outfitted with Bruker instrumentation.
MALDI molecular imaging mass spectrometry reads cell type-specific protein and peptide mass spectra directly from sliced tissues. The imaging resolution of the technique enables differential mass spectrometry analysis of adjacent tissue types within a single tissue slice, such as cancerous versus non-cancerous regions.